Aileron Therapeutics, a biopharmaceutical company, has appointed Steven Kafka, PhD as its first chief financial officer (CFO) and vice president, finance and operations.
Kafka will lead Aileron’s strategic and operational finance activities, direct corporate communications, human resources, and operations and support the company`s business development effort. He will report to Joseph Yanchik III, chief executive officer (CEO).
Kafka brings more than 12 years of experience in finance, strategic planning, business development, operations, corporate communications and early commercial development. Before joining Aileron, he served as vice president, finance for Infinity Pharmaceuticals, where he led finance, investor and public relations and business operations, and was a key member of the team that recently secured an alliance with Purdue Pharma and Mundipharma worth up to US$500m over five years.
Previously, Kafka was senior director, finance, at Millennium Pharmaceuticals, where as an inaugural member of the Velcade product team he drove strategic planning and alliance management efforts with partner Johnson & Johnson. Earlier, he was a senior engagement manager with Strategic Decisions Group, providing product and portfolio strategy consulting to large pharmaceutical companies.
Kafka earned his PhD from Harvard University and his BA with distinction and honours from Stanford University.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more